Related Experiment Video

Updated: Apr 23, 2026

Functional Characterization of Na+/H+ Exchangers of Intracellular Compartments Using Proton-killing Selection to Express Them at the Plasma Membrane
07:38

Functional Characterization of Na+/H+ Exchangers of Intracellular Compartments Using Proton-killing Selection to Express Them at the Plasma Membrane

Published on: March 30, 2015

8.6K

Association of SCN1A gene polymorphisms with infantile spasms and adrenocorticotropic hormone responsiveness

Y Zhang1, L-P Zou, Y-X Ding

  • 1Department of Pediatrics, Chinese PLA General Hospital (No. 301 Hospital of PLA), Beijing, China. lipingzhou9977@163.com.

European Review for Medical and Pharmacological Sciences
|October 1, 2014
PubMed

Insights

Genetic variants in the SCN1A gene are linked to infantile spasms (IS) and predict treatment response to adrenocorticotropic hormone (ACTH) therapy in affected infants.

Area of Science:

  • Genetics
  • Neurology
  • Pediatrics

Background:

  • Infantile spasms (IS) represent a severe form of epilepsy in infants.
  • The SCN1A gene, encoding a key sodium channel subunit, is implicated in various epilepsy syndromes.
  • IS shares symptomatic overlap with SCN1A-associated encephalopathies, suggesting a potential genetic link.

Purpose of the Study:

  • To investigate the association between SCN1A gene polymorphisms and infantile spasms (IS).
  • To determine if SCN1A variants influence the effectiveness of adrenocorticotropic hormone (ACTH) treatment in IS patients.

Main Methods:

  • Genotyping of nine single nucleotide polymorphisms (SNPs) in the SCN1A gene in 113 IS patients and 122 healthy controls.
  • Analysis of SCN1A polymorphisms and their correlation with IS diagnosis and ACTG treatment response.
  • Subgroup analysis comparing cryptogenic and symptomatic IS patients.

Main Results:

  • Two specific SCN1A SNPs (rs13397210 and rs760543) were significantly associated with IS.
  • A four-SNP haplotype (CAGC) in SCN1A correlated with enhanced responsiveness to ACTH therapy (OR = 4.8).
  • Cryptogenic IS patients demonstrated a higher response rate to ACTH compared to symptomatic patients.

Conclusions:

  • Genetic variations within the SCN1A gene are associated with the occurrence of infantile spasms.
  • SCN1A polymorphisms may serve as predictive markers for ACTH treatment responsiveness in IS.
Abstract

More Related Videos

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations08:22

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations

Published on: December 1, 2017

7.9K
Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons08:04

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons

Published on: June 6, 2025

1.5K

Related Concept Videos

Human Genetics01:28

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
2.0K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
80
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
14.1K
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
12.2K
Comparing Copy Number Variations and SNPs02:26

Comparing Copy Number Variations and SNPs

Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
11.4K
Biological Causes of Schizophrenia01:29

Biological Causes of Schizophrenia

Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
1.2K